eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

While automation is definitely part of the goals of artificial intelligence, and in particular automating things that require human cognitive capabilities, simply automating things doesn't make them ...

Almost every enterprise leader I've worked with over the past years has asked a version of the same fundamental question: "How do we maintain operational excellence when our business environment ...

Process automation and control encompasses hardware, software, systems and methods that measure, regulate, manipulate and visualize industrial processes for optimum consistency, efficiency and safety.

Processes and process automation take many forms. Here’s how to navigate the growing ecosystem of tools for automating everything from simple repetitive tasks to complex custom workflows. In 2015, ...

RPA brings to mind humanoid robots replacing human employees, but it’s actually much more benign (and beneficial) than that. With all the recent discussion about the AI-driven ChatGPT, Google Bard and ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the upcoming launch of the EZ2 Connect product line, a next-level automated ...

Bioprocess monitoring is rapidly becoming a tool for achieving process understanding and control and, ultimately, for realizing high yields and quality product. Understanding which analytes matter ...

Signaling its ambitions in the process automation market, Microsoft has acquired Minit, a Bratislava, Slovakia-originated process mining technology vendor, for an undisclosed sum, the companies ...

We’ve seen a lot of trend lines moving throughout 2020 and into 2021 around automation, workflow, robotic process automation (RPA) and the movement to low-code and no-code application building. While ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...